<div><div></div><div><span><p><span>Gilead Sciences Chairman &amp; CEO, Daniel Patrick O'Day, sold 10,000 shares of common stock on December 29, 2025, at a weighted average price of $124.8272 per share, totaling $1,248,272. The sale was conducted under a Rule 10b5-1 trading plan adopted on February 28, 2025. Following the transaction, O'Day directly owns 566,698 shares of Gilead Sciences. Prices for the transactions ranged from $124.40 to $125.16.</span></p><div><table><tbody><tr><td><span>Reporter Name</span></td><td><span>O'Day Daniel Patrick</span></td></tr><tr><td><span>Relationship</span></td><td><span>Chairman &amp; CEO</span></td></tr><tr><td><span>Type</span></td><td><span>Sell</span></td></tr><tr><td><span>Amount</span></td><td><span>$1,248,272</span></td></tr><tr><td><span>SEC Filing</span></td><td>Form 4</td></tr></tbody></table></div><p><span>SEC Filing: </span>GILEAD SCIENCES, INC. [ GILD ] - Form 4 - Dec. 30, 2025</p><section><b><span class="heading-aHOVUrmQ">Disclaimer</span></b><div><span>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</span></div></section></span></div></div>

GILD

<p>Gilead Sciences CEO Daniel Patrick O'Day sold 10,000 shares of the company's stock on December 29, 2025, for a total of $1,248,272 at an average price of $124.83 per share. The sale was part of a Rule 10b5-1 trading plan established earlier in the year. Post-sale, O'Day retains ownership of 566,698 shares.</p>

Gilead Sciences CEO Sells 10,000 Shares